Sinangote, Edita .
HRN: 22-67-57 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/31/2023
CEFUROXIME 1.5GM (VIAL)
04/01/2023
04/01/2023
IV
1.5grams
On Call To OR ANST
For TAHBSO
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes